WGS GeneDx Holdings Corp. Class A Common Stock
XNAS
68.94
Delayed
Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Expected move IV rank history Fibonacci levels Insider trading
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
WGS
$68.94
—
Key stats
$68.94
Pre-market
$68.00
-1.36%
- 52-Week Range
- $32.21 – $170.87
- YTD
- -47.89%
- IV Rank (30D)
- 100.0
- Straddle Price
- $20.05
- P/C Vol Ratio
- 1.49
- Market Cap
- $2.1B
- Open
- $69.16
- Day Range
- $68.25 – $71.53
- Volume
- 832,745
- Prev Close
- $68.74
Fair Value
MODEL: LONG
A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.
- DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
- Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
- DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 2% and dividend payments are stable — below that the dividend is a token payout and Gordon (which values only the dividend stream) systematically underprices growth names, so those route to DCF + comparables + market anchor instead.
- P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
- Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
- Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
- Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
- Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
| 10-yr Treasury (rf) | 5.15% |
| Beta vs SPY | 1.26 |
| Cost of Equity (CAPM) | 12.06% (VRP-adj) |
| WACC | 11.74% |
| Volatility Risk Premium | +53.7pp (IV − HV30), ERP adj +50bps |
| Effective Tax Rate | 21.0% |
| Rev. Growth (YoY, DCF input) | -2.0% |
| DCF Horizon | 10 years explicit + fade |
| Free Cash Flow (TTM) | $-0.1B |
| Return on Equity (TTM) | -43.6% |
| Book / Price | 12.2% |
| Gross Margin (TTM) | 69.4% |
| FCF Margin (TTM) | -16.7% |
| Debt / Equity | 0.40 |
| Quality Score | 2/6 — normal (10y DCF) |
| SMA 50 | $81.11 (Market Anchor value) |
| SMA 20 / Bollinger Mid | $72.08 |
| Bollinger Width / SMA20 | 56.5% (drives anchor stability) |
| Net Debt | $0.0B |
| Market Cap | $2B |
Peers used for multiples: CDNA, CRSP, GH, LLY, MRNA, NTRA, TWST, VCYT
60-Day Conviction
88%
20-Day Fair Value
≈ by Nov 20, 2026
$69.70
α +1.1%
rank 99%
conviction
65%
40-Day Fair Value
≈ by Dec 21, 2026
$72.39
α +5.0%
rank 100%
conviction
98%
60-Day Fair Value
≈ by Jan 19, 2027
$71.42
α +3.6%
rank 99%
conviction
88%
| Method | Implied Price | Weight | Detail |
|---|---|---|---|
| DCF | n/a | 0% | |
| DDM (Gordon) | n/a | 0% | |
| Peer P/E | n/a | 0% | median 32.2× · 3 peers |
| Peer EV/EBITDA | n/a | 0% | median 28.5× · 3 peers |
| Peer P/B | $119.84 | 22% | median 14.3× · 7 peers |
| Peer P/S | $312.48 | 22% | median 20.0× · 8 peers |
| Market Anchor (SMA50) | $81.11 | 0% | stability 0% (BB-width) |
| Options Expected (B-L 30d) | $65.02 | 56% | 55 strikes · skew +0.28 |
As of 2026-10-22 · updated
Related
About
- Industry (SIC)
- SERVICES-HEALTH SERVICES (8000) · industry map
- Exchange
- XNAS
- Market Cap
- $2.1B
- Employees
- 1,300
- List Date
- 2021-07-23
- CIK
- 0001818331
- Next Earnings
- 2026-10-27 (After-Close)
- EPS Forecast
- $0.07 (1 est.)
- Headquarters
- Stamford, CT
- Homepage
- https://www.genedx.com
GeneDx Holdings Corp focuses on genomics, creating the foundation for providing genomic information at scale and pioneering exome and genome sequencing for rare and ultra-rare genetic pediatric disorders. The company believes exome and genome testing will become the standard for diagnosing genetic disease, with the potential to transform healthcare from reactive to proactive. It aims to advance precision medicine by offering genetic diagnoses at the earliest moments, driving improved outcomes, and fueling discovery with genomic intelligence. Its operating segment mainly provides pediatric and …
Summary
—
composite
—
No summary data available for this symbol yet.
Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.
Chart
Seasonality
| Month | '23 | '24 | '25 | '26 | Avg |
|---|---|---|---|---|---|
| Jan | 22.77% | 45.83% | -6.00% | -27.24% | 8.84% |
| Feb | 29.97% | 110.05% | 46.97% | -19.49% | 41.88% |
| Mar | -23.00% | 7.16% | -6.13% | -13.45% | -8.86% |
| Apr | -21.45% | 89.04% | -20.97% | -4.01% | 10.65% |
| May | -9.03% | -6.26% | 14.28% | -20.48% | -5.37% |
| Jun | -14.86% | 21.86% | 24.52% | 32.02% | 15.89% |
| Jul | 25.38% | 14.05% | 12.91% | -7.51% | 11.21% |
| Aug | -41.60% | -0.96% | 27.45% | 24.98% | 2.47% |
| Sep | -19.02% | 38.11% | -15.95% | -14.75% | -2.90% |
| Oct | -50.66% | 89.80% | 20.69% | -2.85%* | 14.25% |
| Nov | -6.91% | 0.84% | 20.72% | -- | 4.88% |
| Dec | 52.78% | -0.49% | -20.51% | -- | 10.59% |
| Total | -68.90% | 2006.05% | 104.29% | -51.09% | 497.59% |
* Only 4 year(s) of data available.
Technical Indicators
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
Trend Indicators
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
Volume & Volatility
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
SMA 20: $72.08
SMA 50: $81.11
SMA 200: $74.05
Current: $68.94
EMA 12: $69.29
EMA 26: $73.75
MACD: -4.4634 | Signal: -0.0006
BEARISH
ADX (14): 23.01
WEAK TREND
+DI: 22.83
−DI: 25.66
Momentum Oscillators
RSI (14): 43.14
NEUTRAL
Stoch %K: 33.84
Stoch %D: 25.61
Williams %R: -60.78
Volume & Volatility
BB Upper: $86.74
BB Lower: $57.41
NEUTRAL
OBV: 429,185
Vol SMA 20: 767,947
Vol ROC: 26.30%
ATR: $5.27
True Range: $3.28
HV 20: 78.7%
HV 30: 79.2%
HV 60: 69.7%
Data Summary
Data Points: 500
Last Updated:
Date Range: 2024-10-23T00:00:00 – 2026-10-21T00:00:00
AI Analysis
LLM Stock Analysis Report - WGS
Executive Summary
Overall Assessment: BEARISH (Confidence Level: 7/10)
Key Drivers:
- Recent negative news headlines related to securities class action lawsuits, which have led to a significant decline in the stock price.
- High volatility, with beta above 1.5, indicating that the stock moves more than the market.
Primary Risks:
- Regulatory issues and potential legal settlements may continue to impact the company's share price.
- The options market is pricing in a high likelihood of further declines, which could lead to increased selling pressure.
Investment Thesis:
WGS presents a challenging investment opportunity due to the significant uncertainty surrounding the company's regulatory environment. While there are some positive fundamentals, such as a relatively low valuation, the recent news headlines and volatility concerns outweigh these factors. A more cautious approach is recommended, with a focus on managing risk rather than seeking alpha.
Recent News Sentiment Impact:
The recent negative news headlines have had a significant impact on the stock price, leading to a decline of approximately 49% over the past few months. This has created a strong bearish sentiment, which is likely to persist until there are some positive developments or a change in market conditions.
Technical Analysis
Trend Direction:
- Short-term (1-4 weeks): Bearish
- Medium-term (1-3 months): Bearish
- Long-term (3-12 months): Neutral
Support/Resistance Levels:
- SMA 20: $64.95 (support)
- EMA 12: $68.08 (resistance)
- Bollinger Bands: $56.22 (lower band), $73.69 (upper band)
Momentum Signals:
- RSI: 65.69 (neutral)
- MACD: Bullish signal, but with a declining histogram
- Stochastic %K/D: Neutral
Volume Analysis:
- Volume SMA 20: 824395.50 (indicating low volume)
- On-Balance Volume (OBV): 4888272.48 (suggesting a potential reversal)
- Volume Rate of Change: 37.29% (indicating increasing volume)
News & Sentiment Analysis
Recent Headlines Summary:
The recent news headlines have been overwhelmingly negative, focusing on securities class action lawsuits and regulatory issues.
Sentiment Assessment:
Aggregate sentiment is strongly bearish, with all six headlines reporting negative developments.
Catalyst Identification:
There are no near-term catalysts that could significantly impact the stock price. However, a change in regulatory environment or a successful resolution of the ongoing legal issues could lead to a rebound.
Market Narrative:
The recent news headlines and volatility concerns have created a strongly bearish market narrative, which is likely to persist until there are some positive developments.
Risk & Volatility Assessment
Risk Assessment:
- Beta: 1.55 (high risk)
- Volatility Regime: High
- Options Market Signals:
- IV Rank: 4.8% (low volatility)
- Current IV: 77.0%
- Expected Move: $13.65 (32 DTE), 7-DTE: $5.75
- Volume Flow: 13 calls vs 46 puts (bearish sentiment)
Downside Protection:
The recent news headlines and volatility concerns have created a strong support level at the SMA 20 ($64.95). However, this level may be tested if the stock price continues to decline.
Market Context & Positioning
Sector Performance:
WGS is trading within its sector, which has been experiencing a decline over the past few months.
Institutional Activity:
There has been significant institutional selling activity in recent weeks, which has contributed to the decline in the stock price.
Correlation Analysis:
The stock has a relatively low correlation with the market (R-squared interpretation), indicating that it may not be closely tied to broader market trends.
Relative Valuation:
WGS is trading at a relatively low valuation compared to its peers and sector averages. However, this is largely due to the recent decline in the stock price.
Key Levels & Action Items
Critical Price Levels:
- SMA 20: $64.95 (support)
- EMA 12: $68.08 (resistance)
Breakout/Breakdown Levels:
- Bollinger Bands: $56.22 (lower band), $73.69 (upper band)
Time-Sensitive Catalysts:
There are no near-term catalysts that could significantly impact the stock price.
Risk Management:
A stop-loss level of around $65-66 could be used to limit potential losses, depending on market conditions and volatility.
Note: This analysis is based solely on publicly available data and should not be considered as investment advice. It's essential to conduct your own research and consult with a financial advisor before making any investment decisions.
Generated
News
All WGS news →
Earnings History
8 of 12 under expected move
Avg Expected Move
21.38%
Avg Actual Move
18.07%
| Earnings Date | Timing | Expected Move | Actual Move | Ratio | Outcome |
|---|---|---|---|---|---|
| 2023-05-09 | After-Close | 29.70% | 2.40% | 0.08x | Within |
| 2023-08-08 | After-Close | 24.51% | 12.63% | 0.52x | Within |
| 2024-04-29 | After-Close | 25.91% | 55.18% | 2.13x | Exceeded |
| 2024-07-30 | After-Close | 28.87% | 8.60% | 0.30x | Within |
| 2024-10-29 | After-Close | 20.00% | 0.98% | 0.05x | Within |
| 2025-01-13 | After-Close | 10.59% | 15.30% | 1.44x | Exceeded |
| 2025-04-30 | Pre-Market | 17.74% | 42.85% | 2.42x | Exceeded |
| 2025-07-29 | Pre-Market | 21.67% | 8.09% | 0.37x | Within |
| 2025-10-28 | Pre-Market | 23.15% | 5.21% | 0.23x | Within |
| 2026-01-12 | Pre-Market | 15.18% | 11.92% | 0.79x | Within |
| 2026-05-04 | After-Close | 17.22% | 49.20% | 2.86x | Exceeded |
| 2026-08-03 | After-Close | 21.96% | 4.48% | 0.20x | Within |
Earnings calendar: this week’s reports with expected vs actual moves →
WGS Options Activity & IV Rank
WGS IV rank history, 52-week IV rank and IV percentile →
Volatility Metrics
Current IV: 128.6%
7-DTE IV: 127.9%
Expected Move: $20.05
7-DTE Move: $11.20
Days to Exp: 30 (2026-11-20)
Options Flow
Call Volume: 977
Put Volume: 1,460
P/C Volume: 1.494
BEARISH
Call OI: 1,592
Put OI: 3,510
P/C OI: 2.205
Total OI: 5,102
ATM Options Pricing
ATM Call: $10.40
ATM Put: $9.65
Call %: 15.1%
Put %: 14.0%
Chain Summary
Chain Volume: 9,228
Chain OI: 18,758
Last Updated: 10/21/2026
Spread Scanner GPU
Each spread is ranked by a composite score built in three stages. Full documentation →
Stage 1 — Base Score (GPU scanner)
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
Stage 2 — Skew Adjustment (±25% cap)
RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Enter a ticker to scan for optimal spread opportunities.
Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.
Dealer Positioning
TYPICAL γ
Estimated net dealer gamma is at the 28th percentile of this name's own daily history, within its typical range. This describes current positioning; it is not a forecast or a trading signal.
Gamma percentile
28%
vs own history
GEX tilt
+0.03
OI-weighted, today
Vanna tilt
+0.32
δ-sensitivity to IV
Charm tilt
-0.37
δ-decay vs time
Vanna tilt +0.32: the estimated dealer exposure leans positive, so the modeled hedge would shift noticeably if implied volatility changed.
Charm tilt -0.37: the estimated dealer exposure leans negative, so the modeled hedge would shift noticeably as time passes and options approach expiry.
? What is this?
· 61 ATM contracts, 3k total OI
Net dealer gamma is an estimate of the aggregate gamma held by options market makers across this name's option chain, weighted by open interest. Dealer positions aren't public, so it uses a standard simplifying assumption: dealers are treated as long the calls and short the puts that are open. Actual dealer books can differ.
Gamma percentile ranks today's estimate against this name's own daily history, from 0% (the lowest reading on record) to 100% (the highest). Raw gamma scales with how much open interest a chain carries, so it isn't comparable across names; the percentile is. The badge marks the bottom 20% as low and the top 20% as high.
Tilts run from −1 to +1 and show how lopsided the estimated dealer exposure is. GEX tilt compares call gamma with put gamma. Vanna tilt describes how the hedge would shift if implied volatility changed, and charm tilt how it would shift with the passage of time.
This card describes estimated positioning and where it sits historically. It is not a forecast of price direction or volatility and not a trading signal. Market-wide view: Dealer positioning screener.
Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Wing vs ATM
IV(put wing) − IV(ATM), in vol pointsHow much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.
- Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
- Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
- Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
- Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each sideWhich side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.
- Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
- Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
- Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
- Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together
Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:
- High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
- Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
- Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d
16%
+0.4
pts
EXTREME
as of Oct 21 · ATM 165.2% / Wing 165.5%
30 DTE / 10d
11%
-0.5
pts
EXTREME
as of Oct 21 · ATM 128.5% / Wing 127.9%
Extreme reading.
Historically these have been contrarian — on the small set of observed earnings-day cases, large negative wing-vs-ATM gaps (calls pricing much richer than puts at the same delta) preceded sharp drops in the underlying within 1-12 days. Not financial advice and the dataset is small.
Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.
Volatility Surface
Enter a ticker to render the implied volatility surface.
Volatility Smile
Enter a ticker to render the implied volatility smile.
IV Rank (7 DTE)49.8MediumOct 21
IV Rank (30 DTE)100.0HighOct 21
Straddle Price (30 DTE)$20.05Oct 21
Beta Analysis
Risk Metrics
Beta: 1.4833
Alpha: -36.40%
Correlation: 0.2200
R-Squared: 4.8%
Stock Volatility: 85.7%
Market Volatility: 12.7%
Analysis Details
Benchmark: SPY
Data Points: 251
Period: 252 trading days
Data Points: 251
Period: 252 trading days
Interpretation:
High volatility - stock moves more than market
High volatility - stock moves more than market
Beta & Alpha Over Time
Notable investors who own WGS
4 of 37 tracked investors
| Investor | Value | Share of their portfolio | Rank | Q/Q shares | Source |
|---|---|---|---|---|---|
| Citadel Hedge fund Ken Griffin | $59.4M | #606 of 6285 | +33.7% | 13F | |
| Millennium Management Hedge fund Izzy Englander | $10.7M | #1534 of 3716 | +3.8% | 13F | |
| Rockefeller Capital Management Family office Rockefeller family | $10.4M | #718 of 4729 | +56.5% | 13F | |
| Point72 Hedge fund Steve Cohen | $6.7M | #893 of 1945 | +28.4% | 13F |
Hedge funds, activists, holding companies and family offices we track, from their latest 13F (quarter-end value) and Form 4 filings in the last 3 years. Family offices · all institutions
WGS Institutional Ownership (13F)
Latest filings — 2026-09-30
? 13F Guide
Diluted shares outstanding: 29,121,182 (as of 2026-06-30)
Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
11 filers$203.21M notional
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | Caption Management, LLC | $59.60M | 29.33% | 2026-06-30 |
| 2 | Citadel Advisors LLC Custodian | $29.78M | 14.65% | 2026-06-30 |
| 3 | Jane Street Group, LLC Custodian | $29.45M | 14.49% | 2026-06-30 |
| 4 | Susquehanna International Group, LLP Custodian | $28.81M | 14.18% | 2026-06-30 |
| 5 | Wolverine Trading, LLC Custodian | $22.59M | 11.12% | 2025-09-30 |
| 6 | Cubist Systematic Strategies, LLC | $7.95M | 3.91% | 2025-09-30 |
| 7 | Point72 Asset Management, L.P. | $7.95M | 3.91% | 2026-06-30 |
| 8 | D. E. Shaw & Co., Inc. Custodian | $7.87M | 3.87% | 2026-06-30 |
| 9 | Walleye Trading LLC | $3.27M | 1.61% | 2026-06-30 |
| 10 | TUDOR INVESTMENT CORP ET AL | $3.17M | 1.56% | 2026-06-30 |
| 11 | PEAK6 LLC | $2.76M | 1.36% | 2026-06-30 |
7 filers$79.19M notional
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | Susquehanna International Group, LLP Custodian | $33.57M | 42.39% | 2026-06-30 |
| 2 | Point72 Asset Management, L.P. | $13.22M | 16.70% | 2026-06-30 |
| 3 | Wolverine Trading, LLC Custodian | $12.68M | 16.01% | 2025-09-30 |
| 4 | Citadel Advisors LLC Custodian | $7.39M | 9.34% | 2026-06-30 |
| 5 | Jane Street Group, LLC Custodian | $6.78M | 8.56% | 2026-06-30 |
| 6 | Cubist Systematic Strategies, LLC | $5.37M | 6.78% | 2025-09-30 |
| 7 | Walleye Trading LLC | $185.35K | 0.23% | 2026-06-30 |
WGS Insider Trading (Form 4)
Latest: 2026-09-18Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
| Filed | Reporter | Role | Action | Shares | Avg Price | Net $ | Link |
|---|---|---|---|---|---|---|---|
| 2026-09-18 | Thomas Fuchs | Director | Exer (M) | +1,146 | — | EDGAR | |
| 2026-09-18 | Katherine Stueland | CHIEF EXECUTIVE OFFICER | Mixed | +8,249 | $97.61 | -$1.03M | EDGAR |
| 2026-09-18 | Kevin Feeley | CHIEF FINANCIAL OFFICER | Mixed | +3,469 | $97.61 | -$363.9K | EDGAR |
| 2026-09-11 | Katherine Stueland | CHIEF EXECUTIVE OFFICER | Mixed | +2,855 | $84.22 | -$310.9K | EDGAR |
| 2026-09-11 | Kevin Feeley | CHIEF FINANCIAL OFFICER | Mixed | +1,177 | $84.22 | -$108.2K | EDGAR |
| 2026-09-03 | Kevin Feeley | CHIEF FINANCIAL OFFICER | Mixed | +345 | $83.84 | -$31.2K | EDGAR |
| 2026-07-01 | Mark A Gardner | President | Grant (A) | +35,441 RSU | — | EDGAR | |
| 2026-06-23 | Richard C Pfenniger Jr | Director | Exer (M) | +3,576 | — | EDGAR | |
| 2026-06-23 | Jason Ryan | Director | Exer (M) | +3,576 | — | EDGAR | |
| 2026-06-23 | Thomas Fuchs | Director | Grant (A) | +4,248 RSU | — | EDGAR | |
| 2026-06-23 | Keith A. Meister | Director | Exer (M) | +3,576 | — | EDGAR | |
| 2026-06-23 | Eli Casdin | Director | Exer (M) | +3,576 | — | EDGAR | |
| 2026-06-23 | Emily M. Leproust | Director | Exer (M) | +3,576 | — | EDGAR | |
| 2026-06-23 | Joshua Ruch | Director | Exer (M) | +3,576 | — | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.
WGS Insider Holdings
9 insiders · @ $68.94
Officers, directors, and 10%+ owners who have filed a Form 4 in the past two years, ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
| # | Insider | Role | Shares | Disclosed Exposure | Lifetime OM Net | Filings | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Eli Casdin | Director | 357,237 | $24.63M | $0 | 1 | 2026-06-23 |
| 2 | Keith A. Meister | Director | 356,849 | $24.60M | $0 | 1 | 2026-06-23 |
| 3 | Katherine Stueland | CHIEF EXECUTIVE OFFICER | 124,181 | $8.56M | -$1.34M | 2 | 2026-09-18 |
| 4 | Jason Ryan | Director | 118,764 | $8.19M | $0 | 1 | 2026-06-23 |
| 5 | Kevin Feeley | CHIEF FINANCIAL OFFICER | 48,087 | $3.32M | -$503.3K | 3 | 2026-09-18 |
| 6 | Joshua Ruch | Director | 45,240 | $3.12M | $0 | 1 | 2026-06-23 |
| 7 | Richard C Pfenniger Jr | Director | 45,082 | $3.11M | $0 | 1 | 2026-06-23 |
| 8 | Emily M. Leproust | Director | 24,852 | $1.71M | $0 | 1 | 2026-06-23 |
| 9 | Thomas Fuchs | Director | 1,146 | $79.0K | $0 | 2 | 2026-09-18 |
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.
WGS Board & Officers
As of SEC filings through Sep 18, 2026Directors 11
- Eli Casdin · since Sep 1, 2020
- Emily M. Leproust · since Sep 1, 2020
- Keith A. Meister · since Sep 1, 2020
- Joshua Ruch · since Jul 22, 2021
- Richard C Pfenniger Jr · since Apr 29, 2022
- Casdin Capital, LLC (entity) · since Jan 31, 2023
- Casdin Partners GP, LLC (entity) · since Jan 31, 2023
- Casdin Partners Master Fund, L.P. (entity) · since Jan 31, 2023
- Corvex Management LP (entity) · since Jan 31, 2023
- Katherine Stueland · listed since May 2023
- Thomas Fuchs · since Sep 17, 2025
Officers 4
- Katherine Stueland · Chief Executive Officer · since Apr 29, 2022
- Mark A Gardner · President · since Jun 15, 2026
- Kevin Feeley · Chief Financial Officer · since Aug 25, 2022
- Bryan Dechairo · Chief Operating Officer · since Jan 2, 2025
10% owners 6
- Casdin Capital, LLC (entity) · since Jan 31, 2023
- Casdin Partners GP, LLC (entity) · since Jan 31, 2023
- Casdin Partners Master Fund, L.P. (entity) · since Jan 31, 2023
- Corvex Management LP (entity) · since Jan 31, 2023
- Eli Casdin · listed since Feb 2023
- Keith A. Meister · listed since Feb 2023
Changes in the last 10 years (113)
| Jun 23, 2026 | Jason Ryan reported in an SEC filing no longer being a director |
| Jun 15, 2026 | Mark A Gardner became President |
| Sep 17, 2025 | Thomas Fuchs became a director |
| Jan 2, 2025 | Bryan Dechairo became Chief Operating Officer |
| Nov 19, 2024 | School Of Medicine At Mount Sinai Icahn reported in an SEC filing no longer being a 10% owner |
| Nov 19, 2024 | Mount Sinai Health System, Inc. reported in an SEC filing no longer being a 10% owner |
| Aug 19, 2024 | Opko Health, Inc. reported in an SEC filing no longer being a 10% owner |
| May 31, 2024 | Casdin Partners FO1-MSV, LP no longer listed as a 10% owner in SEC filings |
| Jan 12, 2024 | Jason Ryan no longer listed as Executive Chairman in SEC filings |
| May 18, 2023 | Katherine Stueland first listed as a director in an SEC filing |
| Apr 24, 2023 | The company announced the departure of Rachel E. Sherman from the board in an SEC filing |
| Feb 14, 2023 | The company announced the departure of Michael J Pellini from the board in an SEC filing |
| Feb 2, 2023 | Keith A. Meister first listed as a 10% owner in an SEC filing |
| Feb 2, 2023 | Eli Casdin first listed as a 10% owner in an SEC filing |
| Jan 31, 2023 | Corvex Management LP became a director |
| Jan 31, 2023 | Corvex Management LP became a 10% owner |
| Jan 31, 2023 | Casdin Partners Master Fund, L.P. became a director |
| Jan 31, 2023 | Casdin Partners Master Fund, L.P. became a 10% owner |
| Jan 31, 2023 | Casdin Partners GP, LLC became a director |
| Jan 31, 2023 | Casdin Partners GP, LLC became a 10% owner |
| Jan 31, 2023 | Casdin Partners FO1-MSV, LP became a director |
| Jan 31, 2023 | Casdin Partners FO1-MSV, LP became a 10% owner |
| Jan 31, 2023 | Casdin Capital, LLC became a director |
| Jan 31, 2023 | Casdin Capital, LLC became a 10% owner |
| Oct 18, 2022 | Jason Ryan first listed as Executive Chairman in an SEC filing |
| Aug 26, 2022 | Richard Miao reported in an SEC filing no longer being Interim CFO |
| Aug 25, 2022 | Kevin Feeley became Chief Financial Officer |
| Aug 10, 2022 | Isaac Ro reported in an SEC filing no longer being Chief Financial Officer |
| Jul 21, 2022 | Kareem Saad listed as Chief Transformation Officer (previously Chief Business Officer) in SEC filings |
| Jun 27, 2022 | The company announced the departure of Shawn Assad as Chief Accounting Officer in an SEC filing |
| Jun 13, 2022 | Richard Miao became Interim CFO |
| Jun 10, 2022 | The company announced the departure of Eric Schadt as President & Chief R&D Officer in an SEC filing |
| May 12, 2022 | Nat Turner reported in an SEC filing no longer being a director |
| May 3, 2022 | Stephen A Schwarzman reported in an SEC filing no longer being a 10% owner |
| May 3, 2022 | Btoa L.l.c. reported in an SEC filing no longer being a 10% owner |
| May 3, 2022 | Bto De Gp - Nq L.l.c. reported in an SEC filing no longer being a 10% owner |
| May 3, 2022 | Blackstone Tactical Opportunities Fund - FD L.P. reported in an SEC filing no longer being a 10% owner |
| May 3, 2022 | Blackstone Tactical Opportunities Associates L.L.C. reported in an SEC filing no longer being a 10% owner |
| May 3, 2022 | Blackstone Tactical Opportunities Associates III - NQ L.P. reported in an SEC filing no longer being a 10% owner |
| May 3, 2022 | Blackstone Inc. reported in an SEC filing no longer being a 10% owner |
| May 3, 2022 | Blackstone Holdings III L.P. reported in an SEC filing no longer being a 10% owner |
| May 3, 2022 | Blackstone Holdings III GP Management L.L.C. reported in an SEC filing no longer being a 10% owner |
| May 3, 2022 | Blackstone Holdings III GP L.P. reported in an SEC filing no longer being a 10% owner |
| May 3, 2022 | Blackstone Holdings II L.P. reported in an SEC filing no longer being a 10% owner |
| May 3, 2022 | Blackstone Holdings I/II GP L.L.C. reported in an SEC filing no longer being a 10% owner |
| May 3, 2022 | Blackstone Holdings I L.P. reported in an SEC filing no longer being a 10% owner |
| May 3, 2022 | Blackstone Group Management L.L.C. reported in an SEC filing no longer being a 10% owner |
| May 3, 2022 | Blackstone Family Tactical Opportunities Investment Partnership III ESC L.P. reported in an SEC filing no longer being a 10% owner |
| May 3, 2022 | Blackstone Aqua Master Sub-Fund, a sub-fund of Blackstone Global Master Fund ICAV reported in an SEC filing no longer being a 10% owner |
| May 3, 2022 | Blackstone Alternative Solutions L.L.C. reported in an SEC filing no longer being a 10% owner |
| May 3, 2022 | BTO Side-by-Side GP L.L.C. reported in an SEC filing no longer being a 10% owner |
| May 3, 2022 | BTO Sema4 Holdings L.P. reported in an SEC filing no longer being a 10% owner |
| May 3, 2022 | BTO Holdings Manager L.L.C. reported in an SEC filing no longer being a 10% owner |
| May 2, 2022 | Eric Schadt listed as President & Chief R&D Officer (previously Chief Executive Officer) in SEC filings |
| Apr 29, 2022 | The company announced the departure of Katherine Stueland from the board in an SEC filing |
| Apr 29, 2022 | Richard C Pfenniger Jr became a director |
| Apr 29, 2022 | Opko Health, Inc. became a 10% owner |
| Apr 29, 2022 | Katherine Stueland became a director |
| Apr 29, 2022 | Katherine Stueland became Chief Executive Officer |
| Jan 25, 2022 | The company announced the departure of James Coffin as President and COO in an SEC filing |
| Jan 25, 2022 | Keith A. Meister no longer listed as a 10% owner in SEC filings |
| Jul 27, 2021 | Eli Casdin no longer listed as a 10% owner in SEC filings |
| Jul 27, 2021 | Eli Casdin no longer listed as Chief Executive Officer in SEC filings |
| Jul 22, 2021 | Stephen A Schwarzman became a 10% owner |
| Jul 22, 2021 | Shawn Assad became Chief Accounting Officer |
| Jul 22, 2021 | School Of Medicine At Mount Sinai Icahn became a 10% owner |
| Jul 22, 2021 | Rachel E. Sherman became a director |
| Jul 22, 2021 | Mount Sinai Health System, Inc. became a 10% owner |
| Jul 22, 2021 | Michael J Pellini became a director |
| Jul 22, 2021 | Karen Ann White became Chief People Officer |
| Jul 22, 2021 | Kareem Saad became Chief Business Officer |
| Jul 22, 2021 | Joshua Ruch became a director |
| Jul 22, 2021 | Jason Ryan became a director |
| Jul 22, 2021 | James Coffin became President and COO |
| Jul 22, 2021 | Isaac Ro became Chief Financial Officer |
| Jul 22, 2021 | Eric Schadt became a director |
| Jul 22, 2021 | Eric Schadt became Chief Executive Officer |
| Jul 22, 2021 | Dennis Charney became a director |
| Jul 22, 2021 | Daniel Emmett Clark became Secretary and General Counsel |
| Jul 22, 2021 | Btoa L.l.c. became a 10% owner |
| Jul 22, 2021 | Bto De Gp - Nq L.l.c. became a 10% owner |
| Jul 22, 2021 | Blackstone Tactical Opportunities Fund - FD L.P. became a 10% owner |
| Jul 22, 2021 | Blackstone Tactical Opportunities Associates L.L.C. became a 10% owner |
| Jul 22, 2021 | Blackstone Tactical Opportunities Associates III - NQ L.P. became a 10% owner |
| Jul 22, 2021 | Blackstone Inc. became a 10% owner |
| Jul 22, 2021 | Blackstone Holdings III L.P. became a 10% owner |
| Jul 22, 2021 | Blackstone Holdings III GP Management L.L.C. became a 10% owner |
| Jul 22, 2021 | Blackstone Holdings III GP L.P. became a 10% owner |
| Jul 22, 2021 | Blackstone Holdings II L.P. became a 10% owner |
| Jul 22, 2021 | Blackstone Holdings I/II GP L.L.C. became a 10% owner |
| Jul 22, 2021 | Blackstone Holdings I L.P. became a 10% owner |
| Jul 22, 2021 | Blackstone Group Management L.L.C. became a 10% owner |
| Jul 22, 2021 | Blackstone Family Tactical Opportunities Investment Partnership III ESC L.P. became a 10% owner |
| Jul 22, 2021 | Blackstone Aqua Master Sub-Fund, a sub-fund of Blackstone Global Master Fund ICAV became a 10% owner |
| Jul 22, 2021 | Blackstone Alternative Solutions L.L.C. became a 10% owner |
| Jul 22, 2021 | BTO Side-by-Side GP L.L.C. became a 10% owner |
| Jul 22, 2021 | BTO Sema4 Holdings L.P. became a 10% owner |
| Jul 22, 2021 | BTO Holdings Manager L.L.C. became a 10% owner |
| Jul 22, 2021 | Anthony Prentice became Chief Product Officer |
| Sep 1, 2020 | Shaun Rodriguez became Chief Strategy Officer |
| Sep 1, 2020 | Sean E George became a director |
| Sep 1, 2020 | Nat Turner became a director |
| Sep 1, 2020 | Munib Islam became a director |
| Sep 1, 2020 | M-Lsh LLC became a 10% owner |
| Sep 1, 2020 | Keith A. Meister became a director |
| Sep 1, 2020 | Keith A. Meister became a 10% owner |
| Sep 1, 2020 | Emily M. Leproust became a director |
| Sep 1, 2020 | Eli Casdin became a director |
| Sep 1, 2020 | Eli Casdin became a 10% owner |
| Sep 1, 2020 | Eli Casdin became Chief Executive Officer |
| Sep 1, 2020 | CMLS Holdings LLC became a 10% owner |
| Sep 1, 2020 | C-Lsh LLC became a 10% owner |
| Sep 1, 2020 | Brian Emes became CFO and Secretary |
Not reported recently (14)
- Casdin Partners FO1-MSV, LP · Last reported as a director in an SEC filing dated Jun 5, 2024
- Kareem Saad · Last reported as Chief Transformation Officer in an SEC filing dated Mar 19, 2024
- Karen Ann White · Last reported as Chief People Officer in an SEC filing dated Jul 27, 2023
- Daniel Emmett Clark · Last reported as Secretary and General Counsel in an SEC filing dated Jul 27, 2022
- Anthony Prentice · Last reported as Chief Product Officer in an SEC filing dated Jul 27, 2022
- Eric Schadt · Last reported as a director in an SEC filing dated May 24, 2022
- Dennis Charney · Last reported as a director in an SEC filing dated Oct 19, 2021
- C-Lsh LLC · Last reported as a 10% owner in an SEC filing dated Sep 1, 2020
- M-Lsh LLC · Last reported as a 10% owner in an SEC filing dated Sep 1, 2020
- Sean E George · Last reported as a director in an SEC filing dated Sep 1, 2020
- CMLS Holdings LLC · Last reported as a 10% owner in an SEC filing dated Sep 1, 2020
- Munib Islam · Last reported as a director in an SEC filing dated Sep 1, 2020
- Shaun Rodriguez · Last reported as Chief Strategy Officer in an SEC filing dated Sep 1, 2020
- Brian Emes · Last reported as CFO and Secretary in an SEC filing dated Sep 1, 2020
Compiled from SEC filings by the company and its directors and officers. Dates are as stated in those filings. Where no filing says when someone left, we show the last filing that listed them.
WGS Proposed Insider Sales (Form 144)
Latest: 2026-09-01
? Form 144 Guide
Last 30d:
0 filings
· Last 90d:
2 filings
· $1.7M notice value
· 2 unique filers
What is Form 144? A notice of intent to sell restricted or control stock under Rule 144. Affiliates (officers, directors, 10%+ owners) and holders of restricted shares must file Form 144 when planning to sell more than 5,000 shares or $50,000 in any 3-month rolling window.
How it relates to Form 4: Form 144 is filed before the trade (up to 90 days in advance); Form 4 is filed within 2 business days after the trade executes. Not every Form 144 results in a sale — the filer may cancel or delay. Look for the corresponding Form 4 on the Insider Activity card to confirm a sale actually happened.
10b5-1 plans: Trades made under a pre-scheduled Rule 10b5-1 plan are not discretionary — they execute automatically on dates set months earlier, regardless of news. High 10b5-1 percentages mean less per-filing signal value, though cumulative selling volume still matters.
"Notice value": Aggregate market value the filer wrote into the Form 144 — i.e. the size of the planned sale, not necessarily the executed dollars. An amended notice (Form 144/A) replaces the original it amends, and cancelled notices are dropped, so neither is double-counted above. A filed value that is clearly inconsistent with the share count at the stock's price (a filer typo) shows as a dash and is left out of the totals.
Source & freshness: Sourced from public Form 144 filings. Refreshed daily; new filings typically appear here the morning after they are filed.
Top 90-day filers:
Katherine Stueland (1, $1.2M) · Kevin Feeley (1, $458K)
| Filed | Filer | Role | Shares | Notice Value | Planned Sale | Broker | Plan | Link |
|---|---|---|---|---|---|---|---|---|
| 2026-09-01 | Kevin Feeley | Officer | 5,410 | $458.5K | 2026-09-01 | Morgan Stanley Smith Barney | — | EDGAR |
| 2026-09-01 | Katherine Stueland | Officer, Director | 14,243 | $1.21M | 2026-09-09 | Morgan Stanley Smith Barney | — | EDGAR |
| 2026-04-29 | Kevin Feeley | Officer | 5,804 | $366.0K | 2026-04-29 | Morgan Stanley Smith Barney | — | EDGAR |
| 2026-04-29 | Katherine Stueland | Director, Officer | 16,415 | $1.04M | 2026-04-29 | Morgan Stanley Smith Barney | — | EDGAR |
| 2026-02-02 | Bryan Dechairo | Officer | 9,374 | $929.9K | 2026-02-02 | Morgan Stanley Smith Barney | 10b5-1 | EDGAR |
| 2026-01-29 | Kevin Feeley | Officer | 24,155 | $2.37M | 2026-01-29 | Morgan Stanley Smith Barney | — | EDGAR |
| 2026-01-29 | Katherine Stueland | Officer, Director | 94,495 | $9.27M | 2026-01-29 | Morgan Stanley Smith Barney | — | EDGAR |
| 2025-11-24 | RUCH JOSHUA | Director | 38,000 | $6.09M | 2025-11-24 | Stifel Nicolaus & Company Inc | — | EDGAR |
| 2025-09-30 | Kevin Feeley | Officer | 5,805 | $625.4K | 2025-09-30 | Morgan Stanley Smith Barney | 10b5-1 | EDGAR |
| 2025-09-30 | Katherine Stueland | Officer, Director | 16,425 | $1.77M | 2025-09-30 | Morgan Stanley Smith Barney | 10b5-1 | EDGAR |
Notice value is the aggregate market value the filer states they intend to sell — not a confirmed transaction. Compare to Insider Activity (Form 4) to see which planned sales actually executed. Market-wide feed: Planned sales (Form 144).
ETF Holders
65 ETFs hold WGS
25 shown · $189.50M total exposure · 0.04% AUM-weighted avg weight
| # | ETF | Provider | Weight | $ Exposure | ETF AUM | As Of |
|---|---|---|---|---|---|---|
| 1 | VTI Vanguard Morningstar Total Stock Market ETF | Vanguard | 0.00% | $48.4M | — | 2026-09-30 |
| 2 | IWM iShares Russell 2000 ETF | iShares (BlackRock) | 0.05% | $34.9M | $75.1B | 2026-10-20 |
| 3 | VXF Vanguard Extended Market ETF | Vanguard | 0.02% | $18.7M | — | 2026-09-30 |
| 4 | IWO iShares Russell 2000 Growth ETF | iShares (BlackRock) | 0.09% | $12.6M | $13.6B | 2026-10-20 |
| 5 | FESM Fidelity Enhanced Small Cap Core ETF | Fidelity | 0.17% | $10.9M | $6.6B | 2026-10-20 |
| 6 | VTWO Vanguard Russell 2000 ETF | Vanguard | 0.05% | $8.4M | — | 2026-09-30 |
| 7 | DFAS Dimensional US Small Cap ETF | Dimensional | 0.02% | $7.9M | — | 2026-10-20 |
| 8 | TSME Thrivent Small-Mid Cap Equity ETF | Nport | 0.67% | $7.0M | — | 2026-06-30 |
| 9 | SCHA Schwab U.S. Small-Cap ETF | Nport | 0.02% | $5.4M | — | 2026-05-31 |
| 10 | DFMC Dimensional US Micro Cap ETF | Dimensional | 0.07% | $4.9M | — | 2026-10-20 |
| 11 | PSC Principal U.S. Small-Cap ETF | Nport | 0.20% | $4.6M | — | 2026-06-30 |
| 12 | VHT Vanguard Health Care ETF | Vanguard | 0.02% | $3.9M | — | 2026-09-30 |
| 13 | FYC First Trust Small Cap Growth AlphaDEX® Fund | First Trust | 0.24% | $3.3M | $1.3B | 2026-10-20 |
| 14 | XHS State Street® SPDR® S&P® Health Care Services ETF | SPDR (State Street) | 1.34% | $3.0M | $221.4M | 2026-10-20 |
| 15 | IHF iShares U.S. Healthcare Providers ETF | iShares (BlackRock) | 0.19% | $2.7M | $1.4B | 2026-10-20 |
| 16 | ITOT iShares Core S&P Total U.S. Stock Market ETF | iShares (BlackRock) | 0.00% | $2.2M | $97.4B | 2026-10-20 |
| 17 | FYX First Trust Small Cap Core AlphaDEX® Fund | First Trust | 0.12% | $1.6M | $1.4B | 2026-10-20 |
| 18 | VTWG Vanguard Russell 2000 Growth ETF | Vanguard | 0.09% | $1.6M | — | 2026-09-30 |
| 19 | GNOM Global X Genomics & Biotechnology ETF | Global X | 1.29% | $1.4M | — | 2026-10-21 |
| 20 | GSSC Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF | Goldman | 0.13% | $1.4M | $1.0B | 2026-10-20 |
| 21 | DCOR Dimensional US Core Equity 1 ETF | Dimensional | 0.00% | $1.3M | — | 2026-10-20 |
| 22 | DFAC Dimensional US Core Equity 2 ETF | Dimensional | 0.00% | $1.1M | — | 2026-10-20 |
| 23 | SMLF iShares U.S. Small-Cap Equity Factor ETF | iShares (BlackRock) | 0.02% | $982,776 | $4.2B | 2026-10-20 |
| 24 | FSML Franklin Small Cap Enhanced ETF | Franklin | 0.49% | $736,412 | $151.3M | 2026-10-20 |
| 25 | RSSL Global X Russell 2000 ETF | Global X | 0.05% | $662,031 | — | 2026-10-21 |
Fundamentals
Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.
Metrics
- Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
- Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
- Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
- Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
- Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
- YoY growth — compare to the same quarter a year earlier to remove seasonality.
- Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
- Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.
TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.
Trailing P/E
—
TTM Diluted EPS
$-3.64
TTM Revenue
$454.43M
TTM Net Income
$-106.61M
TTM Op. Cash Flow
$-48.71M
Quarterly figures (12 quarters)
| Quarter | Period End | Revenue | Net Income | Diluted EPS | Op. Cash Flow |
|---|---|---|---|---|---|
| Q2 '26 | 2026-06-30 | $114.44M | $-17.74M | $-0.60 | $-28.98M |
| Q1 '26 | 2026-03-31 | $102.25M | $-63.57M | $-2.16 | $-32.41M |
| Q4 '25 | 2025-12-31 | $120.99M | $-17.67M | $-0.61 | $-3.09M |
| Q3 '25 | 2025-09-30 | $116.74M | $-7.63M | $-0.27 | $15.77M |
| Q2 '25 | 2025-06-30 | $102.69M | $10.81M | $0.36 | $10.42M |
| Q1 '25 | 2025-03-31 | $87.11M | $-6.45M | $-0.23 | $10.18M |
| Q4 '24 | 2024-12-31 | $95.64M | $5.44M | $0.23 | $-3.18M |
| Q3 '24 | 2024-09-30 | $76.87M | $-8.31M | $-0.31 | $-4.39M |
| Q2 '24 | 2024-06-30 | $70.51M | $-29.17M | $-1.10 | $-4.50M |
| Q1 '24 | 2024-03-31 | $62.42M | $-20.24M | $-0.78 | $-16.41M |
| Q4 '23 | 2023-12-31 | $57.42M | $-25.77M | $-0.92 | $-29.86M |
| Q3 '23 | 2023-09-30 | $53.30M | $-42.29M | $-1.64 | $-41.23M |
Q2 2026 • period ending 2026-06-30 • filed 2026-08-03
Valuation
Ratios derived from TTM financials and the current market price, sampled daily. History chart shows how expensive the stock is today relative to its own recent past.
Price Multiples
- P/E — price / TTM earnings. Rough market rule: 10–15 value, 15–25 market, >30 growth/premium. Negative when earnings are negative.
- P/B — price / book value. Useful for financials and asset-heavy names; meaningless for asset-light software.
- P/S — price / TTM revenue. Useful when earnings are negative or noisy (early-stage growth).
- EV/EBITDA — capital-structure-neutral. <10 cheap, 10–15 reasonable, >20 rich. Good for comparing across leverage profiles.
- EV/Sales — like P/S but accounts for debt + cash. Compare within sector.
Profitability & Yields
- ROE — return on equity. >15% strong, >25% exceptional. Caution: high leverage inflates ROE.
- ROA — return on assets. Leverage-neutral; >5% solid, >10% exceptional.
- Div Yield — annual dividend / price. Compare to 10Y Treasury; sustained yield >6% often signals distress.
- FCF Yield — free cash flow / market cap. >5% is attractive; negative means burning cash.
Balance Sheet
- Debt/Equity — leverage. <1 conservative, >2 aggressive. Sector-dependent (utilities naturally high, tech low).
- Current Ratio — short-term liquidity. >1.5 comfortable, <1 raises short-term solvency flags.
Reading the history chart
- Compare current level to the 3-year band: near the high end = relatively expensive; near the low = relatively cheap.
- Multiples expanding while earnings are flat = sentiment-driven rally.
- Multiples compressing while earnings grow = value coming from fundamentals.
P/E
—
P/B
8.22
P/S
4.42
EV/EBITDA
—
EV/Sales
4.50
ROE
-43.7%
ROA
-22.1%
Div Yield
0.00%
FCF Yield
-2.43%
Debt/Equity
0.40
Current Ratio
—
Market Cap
$2.01B
as of 2026-10-21
Short Interest & Float
Regulatory short-interest reports publish on a bi-weekly settlement cadence; short-volume is reported daily by the trade-reporting facilities. Float is derived from insider-ownership filings.
Metric definitions
- Short Interest — total shares currently sold short as of the settlement date. Lags real time by ~8 business days.
- SI % of Float — short interest / free float. The key crowding metric.
- Days to Cover — short interest / avg daily volume. How many full trading days it would take shorts to buy back. High DTC + catalyst = squeeze fuel.
- Short Vol Ratio — today's short-sale volume / total volume. Intraday selling pressure proxy (not the same as short interest).
- Free Float — shares available for public trading (total shares minus insider / restricted).
- Float % — free float / shares outstanding. <50% = tightly held, more prone to squeezes.
How to read the signals
- SI % of Float < 5% — typical, no particular signal.
- 5–15% — elevated; watch for catalysts (earnings, guidance, macro).
- 15–30% — heavily shorted; tight-float names in this range have produced notable squeezes historically.
- >30% — extreme; borrow is likely expensive and squeeze risk is material.
- Days to Cover > 5 combined with high SI% amplifies squeeze potential.
History chart
- Trend matters more than level. Rapidly rising short interest often precedes negative catalysts or heavy hedging.
- A sudden drop in SI after a rally may indicate a squeeze in progress.
Short interest is reported mid-month and end-of-month; short volume is daily.
Short Interest
5.63M
SI % of Float
29.95%
Days to Cover
5.95
Short Vol Ratio
68.4%
Free Float
18.79M
Float %
63.0%
Short interest 2026-09-30 • Short volume 2026-10-21 • Float 2026-08-24